Latest AI and machine learning research in dementia for healthcare professionals.
BACKGROUND: Early diagnosis of Alzheimer's disease (AD) and related dementias remains challenging because no single biomarker sufficiently captures the complex and multifactorial nature of the underlying pathology. In recent years, multimodal artificial intelligence (AI) models capable of integrating heterogeneous data sources-such as neuroimaging, fluid biomarkers, genetics, and cognitive assessm...
BACKGROUND AND OBJECTIVES: Frontotemporal lobar degeneration TDP43 type C (TDP-C) is a rare and unique neurodegenerative disease that attacks the anterior temporal lobe. Recently, it was shown that Annexin-A11 and TDP-43 coaggregate specifically in TDP-C. Current literature on the genetic associations with TDP-C, reviewed here, lacks a discernible corpus of robust or replicated findings. In this s...
Alzheimer's disease (AD) is the most prevalent type of dementia, and its pathophysiological mechanisms involve multiple factors, including genomic fac...
Alzheimer's disease (AD) is a major cause of dementia, and this paper explores the unclear roles of mitochondrial dysfunction and programmed cell deat...
In the originally published article entitled "A Comprehensive Review on Deep Learning Techniques in Alzheimer's Disease Diagnosis", published in "Curr...
Mild cognitive impairment (MCI) is a critical transitional stage between normal aging and dementia that remains challenging to detect. Many traditiona...
BACKGROUND: Chronic illness may cause a financial burden that affects patients, their caregivers, and families. While international research, mostly f...
Alzheimer's disease, a progressive neurodegenerative disorder, presents a growing global health challenge due to its increasing prevalence and lack of...
BACKGROUND: Predicting Alzheimer's disease (AD)-related cognitive impairment (CI) among cognitively normal (CN) adults enables meaningful disease modi...
Magnetic resonance imaging (MRI) plays a pivotal role in the diagnostic work-up of dementia. In addition to excluding secondary and potentially treata...
Alzheimer's disease (AD) is a dementia disease that causes loss of cognitive functions. Also, it is a noncurable disease. However, early diagnosis and...
BackgroundVascular factors contribute to dementia in approximately 20 million individuals, notably in vascular contributions to cognitive impairment a...
BackgroundDementia disorders are affecting millions of people globally, characterized by memory loss, communication difficulties, and motor function d...
Acute care hospitals often fail to meet the relational needs of older adults with dementia, for whom many environmental stressors can exacerbate behav...
OBJECTIVE: Pre-mortem diagnosis of parkinsonism is often challenging due to atypical presentations, overlapping syndromes, and co-pathologies. This st...
Neurodegenerative diseases (NDs), including Alzheimer's, Parkinson's, Huntington's, amyotrophic lateral sclerosis, and multiple sclerosis, share a com...
BackgroundPredicting cognitive function across dementia stages remains challenging. Plasma biomarkers and electroencephalogram (EEG) features may prov...
BackgroundAcetyl tributyl citrate (ATBC), an eco-friendly plasticizer, exhibits poorly characterized neurotoxic effects.ObjectiveWe integrated network...
BACKGROUND: Observational data are fundamental to medical research but present formidable challenges for causal inference. Machine learning-based caus...
Dementia, a progressively debilitating neurodegenerative disorder, poses a growing challenge to global healthcare due to its subtle early onset and la...